Role of GLP-1 Agonists in Type 2 Diabetes-Associated Sarcopenia | Retatrutide News

The article explores glucose-lowering therapies' potential impact on sarcopenia in type 2 diabetes. It suggests a muscle-centered framework for understa...
Clinical Trials · October 18, 2026